• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Steroid Profiles
  • Steroid Articles
    • Contributors
  • Steroid Forum
MESO-Rx

MESO-Rx

Anabolic Steroids

  • Anabolic Steroids
    • Anadrol
    • Anavar
    • Deca Durabolin
    • Dianabol
    • Equipoise
    • Masteron
    • Oral Turinabol
    • Primobolan Depot
    • Sustanon 250
    • Testosterone
    • Trenbolone Acetate
    • Winstrol Depot
  • hGH & Peptides
    • CJC-1295
    • GHRP-6
    • hGH
    • hCG
    • IGF-1
    • Melanotan II
    • MGF
    • Mod GRF 1-29
    • TB-500
  • Anti-Estrogens
    • Arimidex
    • Aromasin
    • Clomid
    • Letrozole
    • Nolvadex
  • Fat Loss
    • AICAR
    • Albuterol
    • Clenbuterol
    • DNP
    • Ephedrine
    • T3
    • Telmisartan
You are here: Home / Steroid Articles / What are the Best Steroids for Women?

What are the Best Steroids for Women?

April 5, 2012 by Bill Roberts 3 Comments

Geneza Pharma Anadrol

Q: What are the best anabolic steroid for women? Are Anavar and Primobolan the best bets to minimize masculinizing side effects?

A: It may seem surprising but IMO Anadrol (oxymetholone) is a good choice for women who wish to be conservative yet have very effective results.

I don’t specialize in cycles for women and don’t choose to involve myself with it — it almost only happens when the wife of someone I’m working with wants to use some anabolic steroids as well — but I haven’t seen 25 mg/day in divided doses go wrong yet.

Medically, you’d be astonished at the doses women and even girls have taken with very low virilization rates. So anyway, contrary to what intuition might suggest, Anadrol is not one of the riskier choices for women.

That aside, 15 mg/day of Anavar (oxandrolone) will be virilizing in quite a few cases. Probably about 5 mg/day of oxandrolone is comparable to 25 mg/day Anadrol (divided doses) for risk.

Primobolan up to 50 mg/week, divided injections, is a common and reasonable choice, but has some risk: not a particularly high rate though.

I first learned of [Anadrol for women] from Dan Duchaine. In the earlier parts of Denise Rutkowski’s career, he had her on 25 mg/day Anadrol. I don’t think I’m disclosing a secret here because he also published this. She obviously did very well with it and at that point she was not virilized at all. So from him mentioning this to me, I looked further into it.

The medical doses are pretty astonishing. The reason that 50 mg is the tablet size is because that’s the standard minimal medical dose, including for women and children! It used to be used extensively for improving red blood cell count.

I’m sure I could find it again, and I’ve posted it before, but there’s at least one paper in the literature reporting doses used for quite a large number of women and reporting low incidence of any side effects. And these doses were often more than 50 mg/day. Sometimes much more.

And further, personally I’ve never seen 25 mg/day go wrong.

I’m not saying it can’t: you see some women developing hoarse voices and facial hair naturally with time, so there must be some women that are right on the edge. But generally speaking, this is a conservative dose, yet quite effective.

The mg amount that women can tolerate of Anadrol is markedly higher than any other anabolic steroid. However, that said, it’s also true that effect per mg is less, but not enough so to make up the safety difference IMO. I would put 25 mg/day Anadrol (in divided doses) up against 50 mg/week Primo any time for effectiveness and it’s at least equally conservative.

Another thing about Anadrol that’s remarkable is that other anabolic steroids are very easily disruptive of the menstrual cycle. Even dosages such as 2.5 mg oxandrolone 2x/day commonly raise issues. Anadrol however medically has shown often only moderate effect on the menstrual cycle at 50 mg/day, and in my too-limited experience with it (as I generally don’t work with women on steroid cycles) 25 mg/day only lightened and shortened the cycles slightly. Remarkably less disruptive.

As a rough rule of thumb: take a dosage that would be quite moderate for a man, nearly the minimum likely to be recommended that could still give reasonable results for a novice, then divide by 10 to have something that’s moderate but effective for a woman.

(I don’t mean effective in the women’s pro bodybuilding sense.)

For each individual steroid, my suggested mild-but-effective dosage range may differ from the above slightly, and of course the above also is only approximate because there will be diffferent opinions as to what would be moderate for a man. But if having nothing else to work with, if you see or are considering a dosage and want to do a quick “reality check,” the above can help. For example, say that someone is proposing EQ at 100 mg/week. Multiply by 10, and our comparison would be to 1000 mg/week of EQ for a man. That’s well above being a mild cycle. So we can see at a glance that this EQ dose is off, without having had to remember specific values for each steroid.

I’d also take Winstrol out of the equation, as it’s possible (I’m not certain) it has a somewhat worse benefits/risk ratio for women than most other anabolic steroids.

Also in general I’d forget stacking for women.

Returning to the stacks you asked about, and in general to anabolic steroids other than Anadrol for women:

I can’t say that it couldn’t possibly be that some stacking method might give better ratio of muscle gain to side effects, but as to whether we know what that is, that’s another question entirely. The best understood uses are single-drug, and single-drug works fine. Primo or Anadrol are my top two choices for bodybuilding and fitness; oxandrolone is also acceptable but must be lower dosed than those two; for quality of life enhancement, very very low dose testosterone works fine.

Pharmacom Labs Anadrol

About the author

Bill Roberts
Medicinal chemist

Bill Roberts is an internationally-recognized expert on anabolic steroids and performance-enhancing drugs (PEDs). He received a bachelor degree in Microbiology and Cell Science and completed the educational and research requirements for a PhD in Medicinal Chemistry at a major American university.

Bill entered the nutritional supplement industry prior to completing his doctoral thesis but his education was invaluable so far as being able to design/improve nutritional supplement compounds, since it was in the field of designing drug molecules and secondarily some work in transdermal delivery.

His education was not specifically "geared" toward anabolic steroids other than expertise with pharmacological principles having broad applications. This has allowed Bill to provide unique insight into the field of anabolic pharmacology with knowledge of points which he would not have known otherwise.

Filed Under: Steroid Articles, Women and Steroids Tagged With: anadrol, Ask Bill Roberts, women

No replies yet

Start the discussion →

Loading new replies...

Avatar of CensoredBoardsSuck CensoredBoardsSuck May 08, 2016 #1

Would any of the female members that are planning to cycle Anavar soon be willing to substitute A-Bombs instead, and log your results?

Women usually avoid Anadrol because of it's reputation as a strong compound, but the literature has shown it's probably less likely to cause virilization than Anavar, and personal experience has shown that it induces greater gains.

Based on Bill Roberts' experience with women using Anadrol, I've recommended 25 mg qd to several women locally. None reported virilization and all were happy with the results and said they would use it again.

My personal opinion is that Anadrol is a better option for females than Anavar, for several reasons: probably less risk of virilization, better gains, and perhaps most importantly, because it's relatively inexpensive to manufacture, there's less likelihood of a shady source substituting a cheaper, more virilizing steroid in its place.

Because so few women use it there are almost no logs available so I think it would be beneficial to have several women log their experience here at Meso.

If any females are interested, I will post studies that compare the risk of virilization with Anavar.

Reply 14 likes

click to expand...
Avatar of Eman Eman May 08, 2016 #2

@CensoredBoardsSuck what was the average length of the drol cycles for the ladies?

Reply Like

Avatar of Devika Devika May 08, 2016 #3

Would love to read that info, please!
I'm trying to figure out what I want to run for my second cycle.

Reply Like

Avatar of CensoredBoardsSuck CensoredBoardsSuck May 08, 2016 #4

Anywhere from 2 to 3 months.

Reply Like

Avatar of CensoredBoardsSuck CensoredBoardsSuck May 08, 2016 #5

I'll post it when I get to a PC. In the meantime, you can read the Bill Roberts stuff here in the articles section here at Meso.

Reply 1 like

Avatar of Devika Devika May 08, 2016 #6

Very interesting read.
I'll leave it here so other women can read it too:)
Anadrol - Steroids Profile

Reply Like

Avatar of CensoredBoardsSuck CensoredBoardsSuck May 09, 2016 #7

The first study used 100 - 150mg/d oxymetholone in patients (including women) with advanced human immunodeficiency virus (HIV-1) infection. No signs of virilization were observed.

The second study involved the use of oxandrolone in combination with GH in girls with Turner syndrome. Signs of virilization were observed at doses of oxandrolone as low as 0.06mg/kg/d or less (roughly 2.5 mg/d for a 100 lbs female).

From the full text of the oxymethelone study below:

"All patients tolerated the drug(s) well. Potential side-effects of treatment were increased fatigue (n 2) and impotence (n 1). Peripheral oedema, deep venous thrombosis, hypertension, increased libido or signs of virilization were not observed."

[Link to full text: http://journals.cambridge.org/download.php?file=/BJN/BJN75_01/S0007114596000165a.pdf&code=f95be3abec9c4864e4a6c55bf429b91c]​

Br J Nutr. 1996 Jan;75(1):129-38.
Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection.
Hengge UR1, Baumann M, Maleba R, Brockmeyer NH, Goos M.

Abstract
The effect of the testosterone derivative oxymetholone alone or in combination with the H1-receptor antagonist ketotifen, which has recently been shown to block tumour necrosis factor alpha (TNF alpha), on weight gain and performance status in human immunodeficiency virus (HIV) patients with chronic cachexia was evaluated in a 30-week prospective pilot study. Thirty patients were randomly assigned to either oxymetholone monotherapy (n 14) or oxymetholone plus ketotifen (n 16). Patients receiving treatment were compared with a group of thirty untreated matched controls, who met the same inclusion criteria. Body weight and the Karnofsky index, which assesses the ability to perform activities of daily life, and several quality-of-life variables were measured to evaluate response to therapy. The average weight gain at peak was 8.2 (SD 6.2) kg (+ 14.5% of body weight at study entry) in the oxymetholone group (P < 0.001), and 6.1 (SD 4.6) kg (+10.9%) in the combination group (P < 0.005), compared with an average weight loss of 1.8 (SD 0.7) kg in the untreated controls. The mean time to peak weight was 19.6 weeks in the monotherapy group and 20.8 weeks in the combination group. The Karnofsky index improved equally in both groups from 56% before to 67% after 20 weeks of treatment (P < 0.05). The quality of life variables (activities of daily life, and appetite/nutrition) improved in 68% (P < 0.05) and 91% (P < 0.01) of the treated patients respectively. Oxymetholone was safe and promoted weight gain in cachectic patients with advanced HIV-1 infection. The addition of ketotifen did not further support weight gain. These results suggest the need for a randomized, double-blind, placebo-controlled multicentre trial.

J Clin Endocrinol Metab. 2010 Mar;95(3):1151-60.
Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA1, et al.

Abstract
CONTEXT AND OBJECTIVE:
GH therapy increases growth and adult height in Turner syndrome (TS). The benefit to risk ratio of adding the weak androgen oxandrolone (Ox) to GH is unclear.

DESIGN AND PARTICIPANTS:
A randomized, placebo-controlled, double-blind, dose-response study was performed in 10 centers in The Netherlands. One hundred thirty-three patients with TS were included in age group 1 (2-7.99 yr), 2 (8-11.99 yr), or 3 (12-15.99 yr). Patients were treated with GH (1.33 mg/m(2) . d) from baseline, combined with placebo (Pl) or Ox in low (0.03 mg/kg . d) or conventional (0.06 mg/kg . d) dose from the age of 8 yr and estrogens from the age of 12 yr. Adult height gain (adult height minus predicted adult height) and safety parameters were systematically assessed.

RESULTS:
Compared with GH+Pl, GH+Ox 0.03 increased adult height gain in the intention-to-treat analysis (mean +/- sd, 9.5 +/- 4.7 vs. 7.2 +/- 4.0 cm, P = 0.02) and per-protocol analysis (9.8 +/- 4.9 vs. 6.8 +/- 4.4 cm, P = 0.02). Partly due to accelerated bone maturation (P < 0.001), adult height gain on GH+Ox 0.06 was not significantly different from that on GH+Pl (8.3 +/- 4.7 vs. 7.2 +/- 4.0 cm, P = 0.3). Breast development was slower on GH+Ox (GH+Ox 0.03, P = 0.02; GH+Ox 0.06, P = 0.05), and more girls reported virilization on GH+Ox 0.06 than on GH+Pl (P < 0.001).

CONCLUSIONS:
In GH-treated girls with TS, we discourage the use of the conventional Ox dosage (0.06 mg/kg . d) because of its low benefit to risk ratio. The addition of Ox 0.03 mg/kg . d modestly increases adult height gain and has a fairly good safety profile, except for some deceleration of breast development.

Reply 6 likes

click to expand...
Avatar of weighted chinup weighted chinup May 09, 2016 #8

Here's a link to a discussion where BR talks about anadrol use in females as being a better alternative to traditionally used AAS.

I suggest everyone give this one a read - it is an excellent discussion.

Anavar/Primobolan cycle for a female

I always felt that anadrol got an unfair reputation as being harsh. In reality it seems like anadrol probably has one of the best safety profiles out of the oral AAS. I love the stuff personally.

Reply 2 likes

click to expand...
Avatar of CensoredBoardsSuck CensoredBoardsSuck May 09, 2016 #9

Eur J Endocrinol. 2012 Dec 10;168(1):91-9. doi: 10.1530/EJE-12-0404. Print 2013 Jan.
Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
Freriks K1, et al.

Abstract

OBJECTIVE:
Short stature is a prominent feature of Turner syndrome (TS), which is partially overcome by GH treatment. We have previously reported the results of a trial on the effect of oxandrolone (Ox) in girls with TS. Ox in a dose of 0.03 mg/kg per day (Ox 0.03) significantly increased adult height gain, whereas Ox mg/kg per day (0.06) did not, at the cost of deceleration of breast development and mild virilization. The aim of this follow-up study in adult participants of the pediatric trial was to investigate the long-term effects of previous Ox treatment.

DESIGN AND METHODS:
During the previous randomized controlled trial, 133 girls were treated with GH combined with placebo (Pl), Ox 0.03, or Ox 0.06 from 8 years of age and estrogen from 12 years. Sixty-eight women (Pl, n=23; Ox 0.03, n=27; and Ox 0.06, n=18) participated in the double-blind follow-up study (mean age, 24.0 years; mean time since stopping GH, 8.7 years; and mean time of Ox/Pl use, 4.9 years). We assessed height, body proportions, breast size, virilization, and body composition.

RESULTS:
Height gain (final minus predicted adult height) was maintained at follow-up (Ox 0.03 10.2±4.9 cm, Ox 0.06 9.7±4.4 cm vs Pl 8.0±4.6 cm). Breast size, Tanner breast stage, and body composition were not different between groups. Ox-treated women reported more subjective virilization and had a lower voice frequency.

CONCLUSION:
Ox 0.03 mg/kg per day has a beneficial effect on adult height gain in TS patients. Despite previously reported deceleration of breast development during Ox 0.03 treatment, adult breast size is not affected. Mild virilization persists in only a small minority of patients. The long-term evaluation indicates that Ox 0.03 treatment is effective and safe.

J Voice. 2011 Sep;25(5):602-10.
The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
Menke LA1, et al.

Abstract

OBJECTIVES/HYPOTHESIS:
Oxandrolone (Ox) increases height gain but may also cause voice deepening in growth hormone (GH)-treated girls with Turner syndrome (TS). We assessed the effect of Ox on objective and subjective speaking voice frequency in GH-treated girls with TS.

STUDY DESIGN:
A multicenter, randomized, placebo (Pl)-controlled, double-blind study was conducted.

METHODS:
One hundred thirty-three patients were included and treated with GH (1.33 mg/m2/d) from baseline, combined with Pl or Ox in a low (0.03 mg/kg/d) or conventional (0.06 mg/kg/d) dose from the age of 8 years and estrogens from the age of 12 years. Yearly from starting Ox/Pl until 6 months after discontinuing GH+Ox/Pl, voices were recorded and questionnaires were completed.

RESULTS:
At start, mean (±standard deviation [SD]) voice frequency SD score (SDS) was high for age (1.0±1.2, P<0.001) but normal for height. Compared with GH+Pl, voices tended to lower on GH+Ox 0.03 (P=0.09) and significantly lowered on GH+Ox 0.06 (P=0.007). At the last measurement, voice frequency SDS was still relatively high in GH+Pl group (0.6±0.7, P=0.002) but similar to healthy girls in both GH+Ox groups. Voice frequency became lower than -2 SDS in one patient (3%) on GH+Ox 0.03 and three patients (11%) on GH+Ox 0.06. The percentage of patients reporting subjective voice deepening was similar between the dosage groups.

CONCLUSIONS:
Untreated girls with TS have relatively high-pitched voices. The addition of Ox to GH decreases voice frequency in a dose-dependent way. Although most voice frequencies remain within the normal range, they may occasionally become lower than -2 SDS, especially on GH+Ox 0.06 mg/kg/d.

Reply 2 likes

click to expand...
Avatar of weighted chinup weighted chinup May 09, 2016 #10

Bill Roberts also mentioned that oxymethlone doesn't affect the menstrual cycle as much as other AAS:

"Another thing about Anadrol that's remarkable is that other anabolic steroids are very easily disruptive of the menstrual cycle. Even dosages such as 2.5 mg oxandrolone 2x/day commonly raise issues. Anadrol however medically has shown often only moderate effect on the menstrual cycle at 50 mg/day, and in my too-limited experience with it (as I generally don't work with women on steroid cycles) 25 mg/day only lightened and shortened the cycles slightly. Remarkably less disruptive."
​

Source: Anavar/Primobolan cycle for a female

Reply 3 likes

click to expand...
Avatar of CensoredBoardsSuck CensoredBoardsSuck May 09, 2016 #11

AIDS. 2003 Mar 28;17(5):699-710.
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
Hengge UR1, et al.

Abstract
BACKGROUND:
Despite highly active antiretroviral therapy (HAART), chronic involuntary weight loss still remains a serious problem in the care of HIV patients. Various alterations in energy metabolism and endocrine regulation have been found to cause loss of lean body mass (LBM) and body cell mass (BCM). Previous studies in HIV-positive men undergoing androgen replacement therapy or treatment with recombinant growth hormone (rGH) have shown partial restoration of LBM, but these treatments have largely been ineffective in eugonadal individuals.

STUDY DESIGN:
Double-blind, randomized, placebo-controlled trial of 89 HIV-positive women and men with wasting assigned to the anabolic steroid oxymetholone [50 mg twice (BID) or three times daily (TID)] or placebo for 16 weeks followed by open-label treatment. STUDY ENDPOINTS: Body weight, bioimpedance measurements, quality of life parameters and appetite.

RESULTS:
Oxymetholone led to a significant weight gain of 3.0 +/- 0.5 and 3.5 +/- 0.7 kg in the TID and BID groups, respectively (P < 0.05 for each treatment versus placebo), whereas individuals in the placebo group gained an average of 1.0 +/- 0.7 kg. Body cell mass increased in the oxymetholone BID group (3.8 +/- 0.4 kg; P < 0.0001) and in the oxymetholone TID group (2.1 +/- 0.6 kg; P < 0.005), corresponding to 12.4 and 7.4% of baseline BCM, respectively. Significant improvements were noted in appetite and food intake, increased well-being and reduced weakness by self-examination. The most important adverse event was liver-associated toxicity. Overall, 35% of patients in the TID, 27% of patients in the BID oxymetholone group and no patients in the placebo group had a greater than five times baseline increase for alanine aminotransferase during the double-blind phase of the study.

CONCLUSIONS:
Oxymetholone can be considered an effective anabolic steroid in eugonadal male and female patients with AIDS-associated wasting. The BID (100 mg/day) regimen appeared to be equally effective as the TID (150 mg/day) regimen in terms of weight gain, LBM and BCM and was associated with less, but still significant liver toxicity.

Reply 1 like

click to expand...
H Happycamper May 09, 2016 #12

View image at the forums

Reply Like

Avatar of Devika Devika May 09, 2016 #13

I think you may be confusing them.
Anadrol: (Oxymetholone)
Dbol: Dianabol (Methandrostenolone)

Reply 2 likes

H Happycamper May 09, 2016 #14

I like the discussion, mainly @Dr JIM's contribution. None of us are high level competitors or even amateur/novice competitors around here monitored by coaches and physicians so it's good to see a perspective that is rational and with good intentions.

Reply 1 like

H Happycamper May 09, 2016 #15

Yes this user used both I attached the wrong screenshot sorry

Reply Like

Avatar of Dr JIM Dr JIM May 09, 2016 #16

Not to minimize your compliment HC, as its most appreciated by yours truly, but unlike many other self proclaimed AAS forum "guru's" BR is in an elite class of evidence based advisors.

He not only has an advanced degree, (like a day short of his Phd) in a relevant biological field of study, but has assisted innumerable mates involved in SPORT of competitive BB, many at the professional level.

Of even greater significance, Bill Roberts has continued a "push" for a risk adverse approach to anabolic agents, all the while continuing his pursuit of optimizing their benefits.

This becomes more apparent as one reviews and compares his recommendations on; PCT, HCG, AI's, SERMS, and of course AAS dosages, to name a few.

In fact being an idealist, who is genuinely concerned about the BLIND use of AAS that is sooo pervasive on PED forums, one prerequisite of membership would be for every new member to attest to having read (or at least "scanned" for relevancy) all of Bill Roberts ad hoc PED opinions readily available on Meso's home page, BEFORE such members are granted the privilege of posting a NEW THREAD.

I believe reading the aforementioned material could ensure most novices possess the fund of knowledge necessary to begin a NEW THREAD, on questions as rudimentary as; AI dose, PCT on/off duration etc, etc, etc, and could also be used by more seasoned members as a point of reference or recital.

But Im also a realist who likes and appreciates "Happy Campers" :)

Reply 10 likes

click to expand...

Join the full discussion at the MESO-Rx →

Primary Sidebar

Sponsors

Popular Articles

myostatin

The Myostatin Gene

Super Cows and Mighty Mice In 1997, scientists McPherron and Lee revealed to the public the ‘secret’ of an anomaly that livestock breeders have capitalized since the late 1800’s: the gene responsible for big … [Read More...] about The Myostatin Gene

anabolic steroids and aggression

Anabolic Steroids and Aggression, Part 2: Does the Evidence Support a Causal Inference?

Findings regarding the AAS use and aggression relationship are inconsistent and vary with the nature of the study and design. Although widely accepted as fact, a review finds little, if any, strong evidence for a … [Read More...] about Anabolic Steroids and Aggression, Part 2: Does the Evidence Support a Causal Inference?

Axiron - underarm testosterone treatment

Recently Approved and Future Testosterone Related Products

Nelson Vergel, author of "Testosterone: A Man's Guide" discusses several recently approved and future testosterone-related products: Underarm Spray: In an attempt to reduce the risk of transference of … [Read More...] about Recently Approved and Future Testosterone Related Products

isotretinoin

Anabolic Steroids and Acne Vulgaris

Acne, who isn’t familiar with it? Almost everyone ‘catches’ it to some degree or another around puberty. Even many people still suffer from it in adulthood, with the condition estimated to persist into the 20s and … [Read More...] about Anabolic Steroids and Acne Vulgaris

Testosterone Profile

Cheapest and Safest Method of Cycling Steroids

Q: “I want to have really good steroid cycle results over the next year, not like a pro bodybuilder but still very serious. But I don't want to spend a penny more than I have to. What is the cheapest way that's also … [Read More...] about Cheapest and Safest Method of Cycling Steroids

Footer

MESO-Rx International

MESO-Rx articles are also available in the following languages:

Deutsch, English, Español, Français, Português, Русский

Questions? Comments?

Use the following link to send us an e-mail. We will respond as soon as we can.

Contact us.

Search

Copyright © 1997–2025 MESO-Rx. All rights reserved. Disclaimer.